| Najeeb Irtaza Siddique, MD | |
|
745 Poplar Rd, Newnan, GA 30265-1618 | |
| (770) 400-1000 | |
| Not Available |
| Full Name | Najeeb Irtaza Siddique |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 32 Years |
| Location | 745 Poplar Rd, Newnan, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558313726 | NPI | - | NPPES |
| 000860857C | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 042724 (Georgia) | Secondary |
| 207L00000X | Anesthesiology | 42724 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Regional Medical Center | Riverdale, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dpi Of Georgia Llc | 0941546923 | 38 |
| Wellstar Medical Group, Llc | 6709065402 | 1839 |
News Archive
A study that would track the health of 100,000 babies to age 21 has been put on hold following the release of an assessment report issued June 16 by the National Research Council and Institute of Medicine (IOM).
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.
› Verified 4 days ago
| Entity Name | Piedmont Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407856594 PECOS PAC ID: 3577457183 Enrollment ID: O20040212000604 |
News Archive
A study that would track the health of 100,000 babies to age 21 has been put on hold following the release of an assessment report issued June 16 by the National Research Council and Institute of Medicine (IOM).
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.
› Verified 4 days ago
| Entity Name | Amsol Physicians Of Columbus Ga Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114010584 PECOS PAC ID: 2567427495 Enrollment ID: O20041119000765 |
News Archive
A study that would track the health of 100,000 babies to age 21 has been put on hold following the release of an assessment report issued June 16 by the National Research Council and Institute of Medicine (IOM).
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.
› Verified 4 days ago
| Entity Name | Amsol Anesthetists Of Georgia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649224775 PECOS PAC ID: 5193780955 Enrollment ID: O20041122000580 |
News Archive
A study that would track the health of 100,000 babies to age 21 has been put on hold following the release of an assessment report issued June 16 by the National Research Council and Institute of Medicine (IOM).
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.
› Verified 4 days ago
| Entity Name | North Atlanta Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316959869 PECOS PAC ID: 0840291944 Enrollment ID: O20070116000197 |
News Archive
A study that would track the health of 100,000 babies to age 21 has been put on hold following the release of an assessment report issued June 16 by the National Research Council and Institute of Medicine (IOM).
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.
› Verified 4 days ago
| Entity Name | Gwinnett Physician Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578574661 PECOS PAC ID: 9133211139 Enrollment ID: O20070822001035 |
News Archive
A study that would track the health of 100,000 babies to age 21 has been put on hold following the release of an assessment report issued June 16 by the National Research Council and Institute of Medicine (IOM).
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.
› Verified 4 days ago
| Entity Name | Amsol Physicians Of Georgia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134350531 PECOS PAC ID: 1557496783 Enrollment ID: O20100312000866 |
News Archive
A study that would track the health of 100,000 babies to age 21 has been put on hold following the release of an assessment report issued June 16 by the National Research Council and Institute of Medicine (IOM).
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.
› Verified 4 days ago
| Entity Name | Wellstar Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
A study that would track the health of 100,000 babies to age 21 has been put on hold following the release of an assessment report issued June 16 by the National Research Council and Institute of Medicine (IOM).
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.
› Verified 4 days ago
| Entity Name | Northside Primary Care Professional Services,llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922397553 PECOS PAC ID: 9638343924 Enrollment ID: O20111123000206 |
News Archive
A study that would track the health of 100,000 babies to age 21 has been put on hold following the release of an assessment report issued June 16 by the National Research Council and Institute of Medicine (IOM).
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.
› Verified 4 days ago
| Entity Name | Sentry Anesthesia Management, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134544794 PECOS PAC ID: 9436372323 Enrollment ID: O20140521002571 |
News Archive
A study that would track the health of 100,000 babies to age 21 has been put on hold following the release of an assessment report issued June 16 by the National Research Council and Institute of Medicine (IOM).
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.
› Verified 4 days ago
| Entity Name | West Georgia Regenerative Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629555172 PECOS PAC ID: 6507116589 Enrollment ID: O20180912003124 |
News Archive
A study that would track the health of 100,000 babies to age 21 has been put on hold following the release of an assessment report issued June 16 by the National Research Council and Institute of Medicine (IOM).
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.
› Verified 4 days ago
| Entity Name | Dpi Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407323199 PECOS PAC ID: 0941546923 Enrollment ID: O20190111001990 |
News Archive
A study that would track the health of 100,000 babies to age 21 has been put on hold following the release of an assessment report issued June 16 by the National Research Council and Institute of Medicine (IOM).
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.
› Verified 4 days ago
| Entity Name | North Atlanta Anesthesia Professionals, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982349296 PECOS PAC ID: 5496134348 Enrollment ID: O20220623000371 |
News Archive
A study that would track the health of 100,000 babies to age 21 has been put on hold following the release of an assessment report issued June 16 by the National Research Council and Institute of Medicine (IOM).
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Najeeb Irtaza Siddique, MD 616 19th St, Columbus, GA 31901-1528 Ph: (706) 494-4262 | Najeeb Irtaza Siddique, MD 745 Poplar Rd, Newnan, GA 30265-1618 Ph: (770) 400-1000 |
News Archive
A study that would track the health of 100,000 babies to age 21 has been put on hold following the release of an assessment report issued June 16 by the National Research Council and Institute of Medicine (IOM).
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
Candida albicans is a notorious human fungal pathogen that causes thrush and serious systemic infections. Opportunistic C. albicans fungi, which often live inconspicuously in the normal flora of human skin and gut, can switch from their harmless stealth mode to become aggressive pathogens, especially in people whose immune systems are already compromised by pre-existing diseases or harsh drug therapies.
› Verified 4 days ago
Sarah Aileen Jennings-kumagai, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 745 Poplar Rd, Newnan, GA 30265 Phone: 770-400-1000 | |
Dr. Roy Charles Brownlow, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2401 Newnan Crossing Blvd E Ste 120, Newnan, GA 30265 Phone: 770-771-6580 Fax: 707-771-6589 | |
Dr. Brian Everett Caruthers, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 80 Newnan Station Dr, Ste A, Newnan, GA 30265 Phone: 770-251-2060 | |
Dr. Ian Marks, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 80 Newnan Station Dr Ste A, Newnan, GA 30265 Phone: 770-251-2060 Fax: 678-854-9235 | |
Dr. Jaiwantkumar M Avula, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 80 Newnan Station Drive, Suite A, Newnan, GA 30265 Phone: 770-251-2060 Fax: 678-854-9235 | |
Dr. Reinhard Ketsche, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 745 Poplar Rd, Newnan, GA 30265 Phone: 770-400-1000 | |
Oladiran Oladapo Amosu, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 745 Poplar Rd, Newnan, GA 30265 Phone: 770-400-1000 |